Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadaki Suzuki

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Uirusu|March 1, 2016
Investigation of Molecular Mechanism of JC virus Viroporin ActivityTadaki Suzuki
Vaccine|February 3, 2024
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine developmentSho Miyamoto, Tadaki Suzuki
Uirusu|September 21, 2021
[Pathology and Immunology of COVID-19]Shun Iida, Tadaki Suzuki
JMA Journal|August 20, 2021
Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological PerspectiveShun Iida, Takeshi Arashiro, Tadaki Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2007
[Etiological agent and pathogenicity mechanism of PML]Tadaki Suzuki, Kazuo Nagashima, Hirofumi Sawa
Vaccine|August 8, 2017
Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virusTadaki Suzuki, Akira Ainai, Hideki Hasegawa
Communications Medicine|May 20, 2025
Hidden challenges in evaluating spillover risk of zoonotic viruses using machine learning modelsJunna Kawasaki, Tadaki Suzuki, Michiaki Hamada
Advances in Biological Regulation|March 29, 2018
Application of HTLV-1 tax transgenic mice for therapeutic interventionHideki Hasegawa, Kaori Sano, Akira Ainai, et al.
Vaccine|September 4, 2017
The road to a more effective influenza vaccine: Up to date studies and future prospectsKaori Sano, Akira Ainai, Tadaki Suzuki, et al.
Expert Review of Vaccines|August 11, 2018
Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemicsKaori Sano, Akira Ainai, Tadaki Suzuki, et al.
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Uirusu|March 1, 2016
Investigation of Molecular Mechanism of JC virus Viroporin ActivityTadaki Suzuki
Vaccine|February 3, 2024
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine developmentSho Miyamoto, Tadaki Suzuki
Uirusu|September 21, 2021
[Pathology and Immunology of COVID-19]Shun Iida, Tadaki Suzuki
JMA Journal|August 20, 2021
Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological PerspectiveShun Iida, Takeshi Arashiro, Tadaki Suzuki
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2007
[Etiological agent and pathogenicity mechanism of PML]Tadaki Suzuki, Kazuo Nagashima, Hirofumi Sawa
Vaccine|August 8, 2017
Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virusTadaki Suzuki, Akira Ainai, Hideki Hasegawa
Communications Medicine|May 20, 2025
Hidden challenges in evaluating spillover risk of zoonotic viruses using machine learning modelsJunna Kawasaki, Tadaki Suzuki, Michiaki Hamada
Advances in Biological Regulation|March 29, 2018
Application of HTLV-1 tax transgenic mice for therapeutic interventionHideki Hasegawa, Kaori Sano, Akira Ainai, et al.
Vaccine|September 4, 2017
The road to a more effective influenza vaccine: Up to date studies and future prospectsKaori Sano, Akira Ainai, Tadaki Suzuki, et al.
Expert Review of Vaccines|August 11, 2018
Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemicsKaori Sano, Akira Ainai, Tadaki Suzuki, et al.
Pageof 30